Polymorphism of CYP2C19 and Gastric Emptying in Patients with Proton Pump Inhibitor-resistant Gastric Ulcers

By Wada F   Murase K   Isomoto H   Soda H   Takeshima F   Omagari K   Mizuta Y   Tsukamoto K   Murata I   Kohno S  

The Journal of International Medical Research, Vol. 30, Iss. 4, 2002-07 ,pp. : 413-421

Field House Publishing

Access to resources Recommend Favorite

Interaction Between Clopidogrel and Proton Pump Inhibitors: Hypothesis to Explain Multifactorial CYP2C19 Inhibition

By  

Drug Metabolism Letters, Vol. 3, Iss. 4, 2009-12 ,pp. : 287-289

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic and bioequivalence evaluation of single‐tablet and separate‐tablet regimens for once‐daily cobicistat‐boosted elvitegravir in healthy Japanese male subjects: A randomized, two‐way crossover study

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 3, 2015-03 ,pp. : 218-225

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient Preference for Sustained-release versus Standard Paracetamol (Acetaminophen): a Multicentre, Randomized, Open-label, Two-way Crossover Study in Subjects with Knee Osteoarthritis

By Benson M   Marangou A   Russo MA   Durocher J   Collaku A   Starkey YY  

The Journal of International Medical Research, Vol. 37, Iss. 5, 2009-09 ,pp. : 1321-1335

Field House Publishing

Access to resources Recommend Favorite

Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia

By Doki Kosuke   Homma Masato   Kuga Keisuke   Kusano Kazutomi   Watanabe Shigeyuki   Yamaguchi Iwao   Kohda Yukinao  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 11, 2006-11 ,pp. : 919-926

Springer Publishing Company

Access to resources Recommend Favorite